Bonine
NDC Package 63736-044-08
Package Information
Bonine is children 6 years of age and older: chew 1 tablet thoroughly every 6 to 8 hoursdo not exceed 3 tablets in 24 hours or as directed by a doctordosage should be taken up to one hour before travel starts or at onset of symptoms. Marketed by Insight Pharmaceuticals, this product is identified by NDC 63736-044 and is authorized under FDA application part336.
Identification & Billing
- RxCUI: 1251329 - cyclizine HCl 25 MG Chewable Tablet
- RxCUI: 1251329 - cyclizine hydrochloride 25 MG Chewable Tablet
- RxCUI: 1251331 - Bonine For Kids 25 MG Chewable Tablet
- RxCUI: 1251331 - cyclizine hydrochloride 25 MG Chewable Tablet [Bonine For Kids]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals
- 63736-044 - Bonine
- 63736-044-08 - 8 TABLET, CHEWABLE in 1 BOX
- 63736-044 - Bonine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63736-044). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-044-08 identifies a specific commercial package of 8 tablet, chewable in 1 box of Bonine Kids, labeled by Insight Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Insight Pharmaceuticals on June 08, 2009. The current certification is valid through December 31, 2017.
How is this Insight Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736004408. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.